Show simple item record

dc.contributor.authorMOLLOY, ANNEen
dc.date.accessioned2015-12-09T11:27:51Z
dc.date.available2015-12-09T11:27:51Z
dc.date.issued2014en
dc.date.submitted2014en
dc.identifier.citationNzila A, Okombo J, Molloy AM, Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate., Journal of Antimicrobial Chemotherapy, 69, 2, 2014, 323 - 330en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/75123
dc.descriptionPUBLISHEDen
dc.description.abstractMalaria remains the leading cause of mortality and morbidity in children under the age of 5 years and pregnant women. To counterbalance the malaria burden in pregnancy, an intermittent preventive treatment strategy has been developed. This is based on the use of the antifolatesulfadoxine/pyrimethamine, taken at specified intervals duringpregnancy,andreportsshowthatthisapproachreducesthemalariaburdeninpregnancy.Pregnancyisalso associated with the risk of neural tube defects (NTDs), especially in women with low folate status, and folic acid supplementation is recommended in pregnancy to lower the risk of NTDs. Thus, in malaria-endemic areas, preg- nant women have to take both antifolate medication to prevent malaria and folic acid to lower the risk of NTDs. However,theconcomitantuseoffolateandantifolateisassociatedwithadecreaseinantifolateefficacy,exposing pregnant women to malaria. Thus, there is genuine concern that this strategy may not be appropriate. We have reviewedworkcarriedoutonmalariafolatemetabolismandantifolateefficacyinthecontextoffolatesupplemen- tation. This review shows that: (i) the folate supplementation effect on antifolate efficacy is dose-dependent, and folic acid doses required to protect pregnant women from NTDs will not decrease antifolate activity; and (ii) 5- methyl-tetrahydrofolate, the predominant form of folate in the blood circulation, could be administered (even at high dose) concomitantly with antifolate without affecting antifolate efficacy. Thus, strategies exist to protect pregnant women from malaria while maintaining adequate folate levels in the body to reduce the occurrence of NTDs.en
dc.description.sponsorshipA. N. is grateful to the King Fahd University of Petroleum and Minerals (KFUPM) for personal support. J. O. is grateful to The Wellcome Trust of Great Britain for personal support through the training grant WT096394/ Z/11/Z (awarded to Professor Kevin Marsh)en
dc.format.extent323en
dc.format.extent330en
dc.language.isoenen
dc.relation.ispartofseriesJournal of Antimicrobial Chemotherapyen
dc.relation.ispartofseries69en
dc.relation.ispartofseries2en
dc.rightsYen
dc.subjectfolateen
dc.subject.lcshfolateen
dc.titleImpact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/amolloyen
dc.identifier.rssinternalid95206en
dc.identifier.doihttp://dx.doi.org/10.1093/jac/dkt394en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeInternational Developmenten


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record